Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin for Inflow Modulation in LDLT
NCT04107428Phase 4Unknown
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Dec 2019
- Primary completion
- Aug 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of somatostatin in Portal Hypertension (PH), sponsored by King Faisal Specialist Hospital and Research Centre. Status: unknown.
02
Drugs
somatostatin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT04107428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04107428.